RIGL Next Earnings Date Notes

— Rigel Pharmaceuticals (NASDAQ: RIGL) is a biotechnology company focused on discovering, developing, & commercializing innovative small-molecule therapies, primarily targeting hematologic, autoimmune, & rare diseases. Their lead product, TAVALISSE® (fostamatinib), is approved for chronic immune thrombocytopenia (ITP) and is progressing through additional indications that could expand its revenue streams. Investors tuning in to the next earnings call should pay close attention to TAVALISSE sales growth, pipeline progress (particularly key clinical trial updates), & strategic partnerships or new licensing agreements—these are core drivers of long-term performance. Other essential metrics include cash runway, R&D spending relative to milestones achieved, net loss trends, & updates on regulatory submissions in both the U.S. & international markets. Ultimately, monitoring how efficiently Rigel advances its late-stage candidates while managing cash burn will help assess whether the company is likely to succeed in bringing new therapies to patients & achieve sustained profitability. The next projected earnings date for RIGL is 11/3/2026 after close (stay tuned for a confirmed earnings date once announced).

RIGL Next Earnings Date FAQ

On this page we presented the RIGL Next Earnings Date information for Rigel Pharmaceuticals along with recent past earnings dates. For Q2 of 2026, RIGL reported earnings of 0.880/share, with the earnings report taking place on 8/4/2026. For Q1 of 2026, RIGL reported earnings of 0.440/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, RIGL reported earnings of 1.120/share, with the earnings report taking place on 3/3/2026. For Q3 of 2025, RIGL reported earnings of 1.460/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, RIGL reported earnings of 3.280/share, with the earnings report taking place on 8/5/2025. Based on these past earnings dates, the projected next earnings date for RIGL is 11/3/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Rigel Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Rigel Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Rigel Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next RIGL earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up RIGL's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the RIGL next earnings date.